T. Rowe Price Health Care ETF (TMED) 股价，以美元计价

Trimedyne, Inc. is a publicly-held, ISO 13485 Certified manufacturer of lasers and disposable fiber-optic delivery devices cleared for sale by the FDA for use in a variety of minimally-invasive surgical applications, including, urology, lithotripsy, orthopedics, spine, arthroscopy, ENT surgery, gynecology, GI surgery, and general surgery. Trimedyne's lasers and minimally-invasive, patented, single use, side firing fiber-optic devices are used in urology to treat enlarged prostates, and its single use and reusable optical fibers are used to fragment urinary stones in the kidneys, ureter or bladder. Trimedyne's lasers and minimally-invasive, patented, single use, side firing laser needles are also used to treat herniated or ruptured discs in the spine, typically in outpatient procedures. Trimedyne's lasers and proprietary, fiber-optic laser energy delivery devices are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital stays and shorten recuperation time. Trimedyne also owns a broad portfolio of U.S. Patents covering lasers and fiber-optic laser energy delivery devices. Trimedyne leases a modern 28,000 sq. ft. office and manufacturing facility in Lake Forest, California. Trimedyne's wholly-owned subsidiary, Mobile Surgical Technologies, Inc. ("MST") is a "fee per case" provider of lasers, laser operators, and fiber-optic laser energy delivery devices to hospitals, outpatient surgery centers and physicians in Texas and adjoining states, enabling them to avoid buying a laser and hiring and training a technician to operate it. MST is based in Dallas, Texas.